glp-1 obesity drug news Alarming rise in weight loss overdoses What is the pipeline for

BrouwersBRaoGTangYRodrguezGlassLCHartmanML

Semaglutide 2.4 mg, beyond robust weight reduction and improvements in surrogate markers of CVD, such as lipids and glucose, is now associated with benefits for hard CV outcomes CV death, nonfatal MI and nonfatal stroke. Additionally, while presenting cardiometabolic outcomes for retatrutide, Jastreboff said participants who received the 12 mg dose also experienced a mean 40% reduction in triglyceride levels and a mean 22% reduction in LDL cholesterol at 48 weeks, in addition to reductions in HbA1c and blood pressure

Yes, hair loss is a reported side effect of Ozempic (semaglutide)

When you take a GLP-1 drug, it binds to GLP-1 receptors in your pancreas

GLP-1 medications , such as Ozempic and Wegovy, have skyrocketed in popularity and are used to treat type 2 diabetes and aid in weight loss

These advancements ensure that oral medications remain effective despite the digestive environment